Table 3 . Prevalence of the most frequent tolerable side effects occurred in patients of each groups and comparison of them .
Variables | Placebo group | Probiotic group | p-value | ||
Diarrhea | 10th day | 18.2 % | 8.3 % | NS | |
17th day | 10 % | 8.3 % | NS | ||
24th day | 0 | 5.6 % | NS | ||
Epigastric pain | 10th day | 59.1 % | 47.2 % | NS | |
17th day | 40 % | 36.1 % | NS | ||
24th day | 50 % | 39.4 % | NS | ||
Flatulence | 10th day | 50 % | 50 % | NS | |
17th day | 45 % | 45.7 % | NS | ||
24th day | 30% | 55.9 % | NS | ||
Taste abnormality | 10th day | 81.8 % | 77.8 % | NS | |
17th day | 75 % | 61.1 % | NS | ||
24th day | 45 % | 38.2 % | NS | ||
Constipation | 10th day | 40.9 % | 33.3 % | NS | |
17th day | 20 % | 36.1 % | NS | ||
24th day | 15 % | 33.3% | NS | ||
Nausea | 10th day | 26.1 % | 28.6 % | NS | |
17th day | 33.3 % | 36.1 % | NS | ||
24thday | 20 % | 17.6 % | NS | ||
Vomiting | 10th day | 4.3 % | 5.6 % | NS | |
17th day | 4.8 % | 0 | NS | ||
24th day | 0 | 6.1 % | NS | ||
Anorexia | 10th day | 40.9 % | 13.9 % | P< 0.05 | |
17th day | 30 % | 8.3 % | P< 0.05 | ||
24th day | 15 % | 15.2 % | NS |
NS= Not Significant